-
Mashup Score: 29Harvey Wiley Lecture before the Food & Drug Law Institute - 13 hour(s) ago
In 2002, when I arrived at the FDA in my first agency role – as a senior advisor to then Commissioner Mark McClellan, I had already gained some recognition, you could say, for a series of op-eds I had published in the Wall Street Journal’s editorial page about the agency. These articles challenged what I […]
Source: www.aei.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 25
Part of the problem for conservatives — and your loyal podcast hosts are certainly conservatives — is that the left has become so associated with elites and elitism, antisemitism and racism, that there is a temptation to throw the baby out with the bathwater. We ask, listening to the garbage spewed by Ivy League administrators […]
Source: www.aei.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 15Regulating Risky Research: The Science and Governance of Pathogens of Pandemic Potential - 4 month(s) ago
The COVID-19 pandemic has renewed public interest in gain-of-function (GOF) research of concern on pathogens of pandemic potential. Are laboratory experiments to make pathogens more transmissible or virulent necessary for scientific progress? Do such experiments pose unacceptable risk? As Congress and the executive branch consider regulatory reforms, we sorely need constructive, evidence-based discussions of the […]
Source: www.aei.orgCategories: General Medicine News, Infectious DiseaseTweet
My remarks before @foodanddruglaw today on the role for @US_FDA in helping advance a framework for pragmatic evidence generation Paradigm changing technologies require rapid post market learning. FDA can play an active role in these public health settings https://t.co/QSJM1Aylpc